(Total Views: 183)
Posted On: 08/30/2021 7:38:01 AM
Post# of 6
BEYOND AIR: STRONG UPCOMING CATALYSTS MAKE THIS A MUST WATCH!
Beyond Air (NASDAQ:XAIR) is a clinical-stage biopharmaceutical and medical device company that uses a proprietary technology to produce nitric oxide from ambient air through its LungFit System.
The Company has major upcoming catalysts that include the US FDA approval of LungFit® PH ventilator compatible and interim data readouts from Acute viral pneumonia (including COVID19) and Nontuberculous mycobacteria (NTM) lung infection. The Company intends to launch e first in human studies in Multiple Solid Tumors by the end of 2021.
The Company's breakthrough technology can be a potential disruptor in the delivery of Nitric Oxide!
Read on to find out more!
Learn more
https://www.aviseanalytics.com/beyond-air-str...ust-watch/
Beyond Air (NASDAQ:XAIR) is a clinical-stage biopharmaceutical and medical device company that uses a proprietary technology to produce nitric oxide from ambient air through its LungFit System.
The Company has major upcoming catalysts that include the US FDA approval of LungFit® PH ventilator compatible and interim data readouts from Acute viral pneumonia (including COVID19) and Nontuberculous mycobacteria (NTM) lung infection. The Company intends to launch e first in human studies in Multiple Solid Tumors by the end of 2021.
The Company's breakthrough technology can be a potential disruptor in the delivery of Nitric Oxide!
Read on to find out more!
Learn more
https://www.aviseanalytics.com/beyond-air-str...ust-watch/
(0)
(0)
